Literature DB >> 17139292

Bad science in the headlines. Who takes responsibility when science is distorted in the mass media?

Andrew Moore.   

Abstract

Mesh:

Year:  2006        PMID: 17139292      PMCID: PMC1794697          DOI: 10.1038/sj.embor.7400862

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  7 in total

1.  Effect of diets containing genetically modified potatoes expressing Galanthus nivalis lectin on rat small intestine.

Authors:  S W Ewen; A Pusztai
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

2.  Retraction of an interpretation.

Authors:  Simon H Murch; Andrew Anthony; David H Casson; Mohsin Malik; Mark Berelowitz; Amar P Dhillon; Michael A Thomson; Alan Valentine; Susan E Davies; John A Walker-Smith
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

3.  Editorial retraction.

Authors:  Donald Kennedy
Journal:  Science       Date:  2006-01-12       Impact factor: 47.728

4.  Retraction--Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study.

Authors:  Richard Horton
Journal:  Lancet       Date:  2006-02-04       Impact factor: 79.321

5.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

6.  Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study.

Authors:  J Sudbø; J J Lee; S M Lippman; J Mork; S Sagen; N Flatner; A Ristimäki; A Sudbø; L Mao; X Zhou; W Kildal; J F Evensen; A Reith; A J Dannenberg
Journal:  Lancet       Date:  2005 Oct 15-21       Impact factor: 79.321

7.  Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst.

Authors:  Woo Suk Hwang; Young June Ryu; Jong Hyuk Park; Eul Soon Park; Eu Gene Lee; Ja Min Koo; Hyun Yong Jeon; Byeong Chun Lee; Sung Keun Kang; Sun Jong Kim; Curie Ahn; Jung Hye Hwang; Ky Young Park; Jose B Cibelli; Shin Yong Moon
Journal:  Science       Date:  2004-02-12       Impact factor: 47.728

  7 in total
  3 in total

1.  Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy.

Authors:  Abdulmaged M Traish; Jay C Vance; Abraham Morgentaler
Journal:  EMBO Rep       Date:  2016-12-05       Impact factor: 8.807

2.  Primum non nocere: a call for balance when reporting on CTE.

Authors:  William Stewart; Kieren Allinson; Safa Al-Sarraj; Corbin Bachmeier; Karen Barlow; Antonio Belli; Mark P Burns; Alan Carson; Fiona Crawford; Kristen Dams-O'Connor; Ramon Diaz-Arrastia; C Edward Dixon; Brian L Edlow; Scott Ferguson; Bruce Fischl; Rebecca D Folkerth; Steve Gentleman; Christopher C Giza; M Sean Grady; Adel Helmy; Mark Herceg; Janice L Holton; David Howell; Peter J Hutchinson; Diego Iacono; Juan E Iglesias; Milos D Ikonomovic; Victoria E Johnson; C Dirk Keene; Julia K Kofler; Vassilis E Koliatsos; Edward B Lee; Harvey Levin; Jonathan Lifshitz; Helen Ling; David J Loane; Seth Love; Andrew Ir Maas; Niklas Marklund; Christina L Master; Damien M McElvenny; David F Meaney; David K Menon; Thomas J Montine; Benoit Mouzon; Elliott J Mufson; Joseph O Ojo; Mayumi Prins; Tamas Revesz; Craig W Ritchie; Colin Smith; Richard Sylvester; Cheuk Y Tang; John Q Trojanowski; Kathryn Urankar; Robert Vink; Cheryl Wellington; Elisabeth A Wilde; Lindsay Wilson; Keith Yeates; Douglas H Smith
Journal:  Lancet Neurol       Date:  2019-02-12       Impact factor: 44.182

3.  A science impact framework to measure impact beyond journal metrics.

Authors:  Mary D Ari; John Iskander; John Araujo; Christine Casey; John Kools; Bin Chen; Robert Swain; Miriam Kelly; Tanja Popovic
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.